STERIS director granted options and RSUs
Martin Paul Edward reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Martin Paul Edward reported acquisition or exercise transactions in this Form 4 filing.
STERIS plc director Martin Paul Edward reported compensation-related equity grants. He received 1,506 nonqualified stock options exercisable immediately at $238.91 per share, expiring August 10, 2036, and 512 Career Restricted Stock Units, which are fully vested and will be settled in ordinary shares six months after his Board service ends, bringing his directly held Career RSUs to 5,074.
Insider Trade Summary
Grant/Award: 2,018 shares
Grant/Award
2 txns
Insider
Martin Paul Edward
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Director Stock Option (right to buy) F1 | 1,506 | $0.00 | $0.00 |
| Grant/Award | Career Restricted Stock Units F2, F3 | 512 | $0.00 | $0.00 |
Holdings After Transaction:
Director Stock Option (right to buy) — 1,506 contracts (Direct);
Career Restricted Stock Units — 5,074 contracts (Direct)
Footnotes (3)
- F1. These nonqualified stock options are fully vested and are exercisable immediately.
- F2. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.
- F3. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.
Key Figures
Nonqualified stock options granted: 1,506 shares
Option exercise price: $238.91 per share
Option expiration date: August 10, 2036
+2 more
5 metrics
Nonqualified stock options granted
1,506 shares
Director stock option grant on 2026-08-10
Option exercise price
$238.91 per share
Director nonqualified stock options exercisable immediately
Option expiration date
August 10, 2036
Term of director nonqualified stock options
Career RSUs granted
512 units
Career Restricted Stock Units awarded on 2026-08-10
Career RSUs following grant
5,074 units
Director’s total directly held Career RSUs after transaction
Key Terms
nonqualified stock options, Career Restricted Stock Units, Rule 10b5-1
3 terms
nonqualified stock options financial
"These nonqualified stock options are fully vested and are exercisable immediately"
A nonqualified stock option is a company-issued right that lets an employee or contractor buy shares later at a preset price, like a coupon to purchase stock regardless of the market price. It matters to investors because when the option is used the recipient owes ordinary-income tax on the difference between market and preset price, which affects the holder’s financial decisions and can change the company’s share count and reported expenses.
Career Restricted Stock Units financial
"Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share"
Rule 10b5-1 regulatory
"The disclosure indicates the Rule 10b5-1 checkbox was not marked"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did STERIS (STE) director Martin Paul Edward receive?
Martin Paul Edward received 1,506 nonqualified stock options and 512 Career Restricted Stock Units as compensation. Both awards are fully vested, with differing exercise and settlement terms tied to his Board service.
What is the exercise price and term of the new STERIS (STE) director stock options?
The new director stock options have an exercise price of $238.91 per share and expire on August 10, 2036. They are nonqualified stock options and, per the disclosure, are fully vested and exercisable immediately upon grant.
How do the Career Restricted Stock Units for STERIS (STE) director settle?
Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share. These units are fully vested and will be settled in ordinary shares six months after the cessation of the director’s Board service, rather than immediately.
How many Career Restricted Stock Units does the STERIS (STE) director hold after this grant?
After the grant of 512 Career Restricted Stock Units, the director’s total directly held Career RSUs reported is 5,074. This figure reflects his position in this type of derivative security following the reported transaction.
Were the reported STERIS (STE) director equity transactions under a Rule 10b5-1 plan?
The disclosure indicates the Rule 10b5-1 checkbox was not marked as an affirming trading plan. The transactions are reported as grant or award acquisitions rather than trades executed under a pre-arranged 10b5-1 plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
